Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness – United States

By sjmartinez • March 1, 2024

Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang DH, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. MMWR Morb Mortal Wkly Rep. 2024 Feb 29;73(8):168-174. doi: 10.15585/mmwr.mm7308a3. PMID: 38421935.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study

Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa[...]

Homelessness and Risk of End-Stage Kidney Disease and Death in Veterans With Chronic Kidney Disease

Koyama AK, Nee R, Yu W, Choudhury D, Heng F, Cheung AK, Cho ME, Norris KC, Yan G. Homelessness and Risk of End-Stage Kidney Disease[...]

Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease

Galindo RJ, Soliman D, Cherñavvsky D, Rhee CM. Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease. Diabetologia. 2024 Sep 10. doi:[...]